Works matching AU Schöffski, P.

Results: 30

Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors.

Published in:

2010

By:

Schöffski, P.;
Garfield, D. H.;
Hercbergs, A.;
Wolter, P.;
Schöffski, P

Publication type:

Letter

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation.

Published in:

2008

By:

Wolter, P.;
Stefan, C.;
Decallonne, B.;
Dumez, H.;
Bex, M.;
Carmeliet, P.;
Schöffski, P.;
Schöffski, P

Publication type:

journal article

Clinical implications of mutational analysis in gastrointestinal stromal tumours.

Published in:

2008

By:

Hoeben, A;
Schöffski, P;
Debiec-Rychter, M;
Schöffski, P

Publication type:

journal article

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer.

Published in:

2003

By:

Van den Brande, J.;
Schöffski, P.;
Schellens, J. H. M.;
Roth, A. D.;
Duffaud, F.;
Weigang-Köhler, K.;
Reinke, F.;
Wanders, J.;
de Boer, R. F.;
Vermorken, J. B.;
Fumoleau, P.;
Schöffski, P;
Weigang-Köhler, K

Publication type:

journal article

Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration.

Published in:

2000

By:

Schöffski, P.;
Ganser, A.;
Pascheberg, U.;
Büsche, G.;
Gaede, B.;
Hertenstein, B.;
Schöffski, P;
Büsche, G

Publication type:

journal article

Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis".

Published in:

Sarcoma, 2021, p. 1, doi. 10.1155/2021/4653987

By:

Schöffski, P.;
Timmermans, I.;
Hompes, D.;
Stas, M.;
Boecxstaens, Veerle;
Sinnaeve, F.;
De Leyn, P.;
Coosemans, W.;
Van Raemdonck, D.;
Hauben, E.;
Sciot, R.;
Clement, P.;
Bechter, O.;
Beuselinck, B.;
Woei-A-Jin, F. J. S. H.;
Dumez, H.;
Nafteux, P.;
Wessels, T.

Publication type:

Article

Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis.

Published in:

Sarcoma, 2020, p. 1, doi. 10.1155/2020/1385978

By:

Schöffski, P.;
Timmermans, I.;
Hompes, D.;
Stas, M.;
Sinnaeve, F.;
De Leyn, P.;
Coosemans, W.;
Van Raemdonck, D.;
Hauben, E.;
Sciot, R.;
Clement, P.;
Bechter, O.;
Beuselinck, B.;
Woei-A-Jin, F. J. S. H.;
Dumez, H.;
Nafteux, P.;
Wessels, T.

Publication type:

Article

Ecteinascidin-743: evidence of activity in advanced, pretreated soft tissue and bone sarcoma patients.

Published in:

2006

By:

Huygh G;
Clement PMJ;
Dumez H;
Schöffski P;
Wildiers H;
Selleslach J;
Jimeno JM;
De Wever I;
Sciot R;
Duck L;
Van Oosterom AT

Publication type:

Journal Article

Ecteinascidin-743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma Patients.

Published in:

Sarcoma, 2006, v. 2006, p. 1, doi. 10.1155/SRCM/2006/56282

By:

Huygh, G.;
Clement, Paul M. J.;
Dumez, H.;
Schöffski, P.;
Wildiers, H.;
Selleslach, J.;
Jimeno, J. M.;
DeWever, I.;
Sciot, R.;
Duck, L.;
Van Oosterom, A. T.

Publication type:

Article

RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs.

Published in:

2015

By:

Beuselinck, B;
Jean-Baptiste, J;
Couchy, G;
Job, S;
De Reynies, A;
Wolter, P;
Théodore, C;
Gravis, G;
Rousseau, B;
Albiges, L;
Joniau, S;
Verkarre, V;
Lerut, E;
Patard, J J;
Schöffski, P;
Méjean, A;
Elaidi, R;
Oudard, S;
Zucman-Rossi, J;
Théodore, C

Publication type:

journal article

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.

Published in:

British Journal of Cancer, 2015, v. 113, n. 1, p. 12, doi. 10.1038/bjc.2015.196

By:

Gore, M E;
Szczylik, C;
Porta, C;
Bracarda, S;
Bjarnason, G A;
Oudard, S;
Lee, S-H;
Haanen, J;
Castellano, D;
Vrdoljak, E;
Schöffski, P;
Mainwaring, P;
Hawkins, R E;
Crinò, L;
Kim, T M;
Carteni, G;
Eberhardt, W E E;
Zhang, K;
Fly, K;
Matczak, E

Publication type:

Article

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.

Published in:

2013

By:

Gits, C M M;
van Kuijk, P F;
Jonkers, M B E;
Boersma, A W M;
van Ijcken, W F;
Wozniak, A;
Sciot, R;
Rutkowski, P;
Schöffski, P;
Taguchi, T;
Mathijssen, R H J;
Verweij, J;
Sleijfer, S;
Debiec-Rychter, M;
Wiemer, E A C

Publication type:

journal article

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.

Published in:

British Journal of Cancer, 2013, v. 109, n. 6, p. 1625, doi. 10.1038/bjc.2013.483

By:

Gits, C M M;
van Kuijk, P F;
Jonkers, M B E;
Boersma, A W M;
van IJcken, W F;
Wozniak, A;
Sciot, R;
Rutkowski, P;
Schöffski, P;
Taguchi, T;
Mathijssen, R H J;
Verweij, J;
Sleijfer, S;
Debiec-Rychter, M;
Wiemer, E A C

Publication type:

Article

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.

Published in:

British Journal of Cancer, 2013, v. 108, n. 4, p. 887, doi. 10.1038/bjc.2012.548

By:

Beuselinck, B;
Karadimou, A;
Lambrechts, D;
Claes, B;
Wolter, P;
Couchy, G;
Berkers, J;
Paridaens, R;
Schöffski, P;
Méjean, A;
Verkarre, V;
Lerut, E;
de la Taille, A;
Tourani, J-M;
Bigot, P;
Linassier, C;
Négrier, S;
Berger, J;
Patard, J-J;
Zucman-Rossi, J

Publication type:

Article

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases.

Published in:

British Journal of Cancer, 2012, v. 107, n. 10, p. 1665, doi. 10.1038/bjc.2012.385

By:

Beuselinck, B;
Wolter, P;
Karadimou, A;
Elaidi, R;
Dumez, H;
Rogiers, A;
Van Cann, T;
Willems, L;
Body, J-J;
Berkers, J;
Van Poppel, H;
Lerut, E;
Debruyne, P;
Paridaens, R;
Schöffski, P

Publication type:

Article

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.

Published in:

British Journal of Cancer, 2012, v. 107, n. 7, p. 1025, doi. 10.1038/bjc.2012.371

By:

Ploquin, A;
Olmos, D;
Lacombe, D;
A'Hern, R;
Duhamel, A;
Twelves, C;
Marsoni, S;
Morales-Barrera, R;
Soria, J-C;
Verweij, J;
Voest, E E;
Schöffski, P;
Schellens, J H;
Kramar, A;
Kristeleit, R S;
Arkenau, H-T;
Kaye, S B;
Penel, N

Publication type:

Article

Rituximab-induced fatal interstitial pneumonitis: case report.

Published in:

Leukemia & Lymphoma, 2010, v. 51, n. 3, p. 546, doi. 10.3109/10428190903518303

By:

Vulsteke, C.;
Dierickx, D.;
Verbeken, E.;
Wolter, P.;
Thomas, J.;
Schöffski, P.

Publication type:

Article

Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer.

Published in:

2002

By:

Bokemeyer, C.;
Ochsle, K.;
Hartmann, J.T.;
Schoffski, P.;
Schleucher, N.;
Metzner, B.;
Schleicher, J.;
Kanz, L.;
Oechsle, K;
Schöffski, P

Publication type:

journal article

Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies.

Published in:

2011

By:

Schöffski P;
Dumez H;
Ruijter R;
Miguel-Lillo B;
Soto-Matos A;
Alfaro V;
Giaccone G

Publication type:

Journal Article

Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1397, doi. 10.1007/s00280-011-1612-1

By:

Schöffski, P.;
Dumez, H.;
Ruijter, R.;
Miguel-Lillo, B.;
Soto-Matos, A.;
Alfaro, V.;
Giaccone, G.

Publication type:

Article

A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 4, p. 579, doi. 10.1007/s00280-007-0509-5

By:

Clamp, A.;
Schöffski, P.;
Valle, J.;
Wilson, R.;
Marreaud, S.;
Govaerts, A.-S.;
Debois, M.;
Lacombe, D.;
Twelves, C.;
Chick, J.;
Jayson, G.

Publication type:

Article

Bendamustime: A Viewpoint by Patrick Schöffski and Arnold Ganser.

Published in:

Drugs, 2001, v. 61, n. 5, p. 639

By:

Schöffski, P.;
Ganser, A.

Publication type:

Article

Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels.

Published in:

1999

By:

Schöffski, P;
Tacke, F;
Ganser, A;
Trautwein, C;
Martin, M U;
Petersen, D

Publication type:

commentary

Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors.

Published in:

Investigational New Drugs, 2013, v. 31, n. 3, p. 734, doi. 10.1007/s10637-012-9880-0

By:

Awada, A.;
Dumez, H.;
Hendlisz, A.;
Wolter, P.;
Besse-Hammer, T.;
Uttenreuther-Fischer, M.;
Stopfer, P.;
Fleischer, F.;
Piccart, M.;
Schöffski, P.

Publication type:

Article

A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors.

Published in:

2012

By:

Vilar E;
Grünwald V;
Schöffski P;
Singer H;
Salazar R;
Iglesias JL;
Casado E;
Cullell-Young M;
Baselga J;
Tabernero J

Publication type:

Journal Article

Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report.

Published in:

Transplant Infectious Disease, 2015, v. 17, n. 2, p. 303, doi. 10.1111/tid.12357

By:

Detroyer, D.;
Deraedt, K.;
Schöffski, P.;
Hauben, E.;
Lagrou, K.;
Naesens, M.;
Delforge, M.‐L.;
Kuypers, D.

Publication type:

Article

Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification.

Published in:

Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 546, doi. 10.1007/s12094-019-02158-z

By:

Cornillie, J.;
Wozniak, A.;
Li, H.;
Gebreyohannes, Y. K.;
Wellens, J.;
Hompes, D.;
Debiec-Rychter, M.;
Sciot, R.;
Schöffski, P.

Publication type:

Article

Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease.

Published in:

Scandinavian Journal of Gastroenterology, 2004, v. 39, n. 3, p. 259, doi. 10.1080/00365520310008340

By:

Tacke, F.;
Schöffski, P.;
Luedde, T.;
Meier, P.N.;
Ganser, A.;
Manns, M.P.;
Trautwein, C.

Publication type:

Article

Pazopanib in the treatment of soft tissue sarcoma.

Published in:

2012

By:

Schöffski P

Publication type:

Journal Article

Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy.

Published in:

Leukemia (08876924), 2015, v. 29, n. 1, p. 11, doi. 10.1038/leu.2014.222

By:

Gjertsen, B T;
Schöffski, P

Publication type:

Article